Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

BACKGROUND: The ORBE II study aimed to describe the characteristics and clinical outcomes of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real-world setting in Spain. METHODS: ORBE II (NCT04648839) was an observational, retrospective cohort study in adult SEA p...

Descripción completa

Detalles Bibliográficos
Autores principales: Padilla-Galo, Alicia, Moya Carmona, Isabel, Ausín, Pilar, Carazo Fernández, Luis, García-Moguel, Ismael, Velasco-Garrido, José Luis, Andújar-Espinosa, Rubén, Casas-Maldonado, Francisco, Martínez-Moragón, Eva, Martínez Rivera, Carlos, Vera Solsona, Elisabet, Sánchez-Toril López, Fernando, Trisán Alonso, Andrea, Blanco Aparicio, Marina, Valverde-Monge, Marcela, Valencia Azcona, Borja, Palop Cervera, Marta, Nuevo, Javier, Sánchez Tena, Jesús, Resler, Gustavo, Luzón, Elisa, Levy Naon, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540395/
https://www.ncbi.nlm.nih.gov/pubmed/37770889
http://dx.doi.org/10.1186/s12931-023-02539-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540395/
https://www.ncbi.nlm.nih.gov/pubmed/37770889
http://dx.doi.org/10.1186/s12931-023-02539-7

Ejemplares similares